NON-INVASIVE OPTICAL DETECTION OF BLOOD GLUCOSE BASED ON PHASE MASKS

• US 20130178723A1
• Filed: 03/04/2013
• Published: 07/11/2013
• Est. Priority Date: 06/20/2008
• Status: Active Grant

• Current Assignee: Alethus, Inc.
• Original Assignee: Alethus, Inc.
• Inventors: Wang, Feiling
• Granted Patent: US 9,211,088 B2
• Time in Patent Office: Days
• US Class Current: 600/316
• CPC Class Codes: A61B 5/0073 by tomography, i.e. reconstruction of 3D images from 2D projections A61B5/0066 takes precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters

Abstract

Non-invasive [blood] glucose testing devices and testing methods without using a blood sample are disclosed and can be used for optically interrogating substances overlaid by turbid media based on wavefront manipulation by means of binary phase masking. Through altering the degree of mode conformity between the fields reaching the collection optics and the field distributions of the propagation modes of optical waveguides the disclosed method can be used to suppress the collection of short-range light originated near the collection optics while permitting unimpeded collection of light originated from sites substantially behind turbid media.

Claims

1. A non-invasive [blood] glucose testing device without using a blood sample, comprising:

a device housing that forms an enclosure;

a plate in the device housing that is structured to include an optical window that transmits light and provides a surface for a person to place a finger for performing a [blood] glucose test;

a light source located inside the device housing to produce probe light that transmits through the optical window to reach the finger and to produce returned probe light from the finger which carries information of an illuminated part of the finger for performing the [blood] glucose test;

a phase mask device located inside the device housing in an optical path of the returned probe light from the optical window to exert one or more spatial binary phase patterns onto the returned probe light;

a single-mode optical fiber segment located inside the device housing and configured to include an input terminal located to receive the returned probe light output by the phase mask device and an output terminal to output light;

a focusing optical unit located inside the device housing in an optical path of the returned probe light between the phase mask device and the input terminal of the single-mode optical fiber to focus a portion of the returned probe light from the phase mask into an optical mode of the input terminal of the single-mode optical fiber while directing remainder of the returned probe light from the phase mask to miss the input terminal of the single-mode optical fiber, wherein the one or more spatial binary phase patterns are configured to cause the returned probe light at the input terminal to be in an optical mode different from the optical mode of the single-mode optical fiber; and

an optical detection module located inside the device housing and positioned to receive output light from the output terminal of the single-mode optical fiber segment to produce a detection output containing information of a [blood] glucose level.

2. The device as in claim 1, wherein:

the phase mask device is configured so that each spatial binary phase pattern includes two or more different binary phase regions of phase values of zero or π

.

3. The device as in claim 1, wherein:

the phase mask device is configured so that each spatial binary phase pattern includes two or more different binary phase regions that have different phase values between two adjacent binary phase regions.

4. The device as in claim 1, wherein:

the phase mask device is configured so that each spatial binary phase pattern includes two or more different binary phase regions that cause a portion of the returned probe light from the epidermis part of the finger to miss the input terminal of the single-mode optical fiber and cause a portion of the returned probe light from the dermis part of the finger to enter the input terminal of the single-mode optical fiber.

5. The device as in claim 1, wherein:

the phase mask device is configured to produce two or more different spatial binary phase patterns each having two or more different binary phase regions so that two different spatial binary phase patterns are mutually orthogonal in that light having one binary phase pattern can be directed by the focusing optical unit into the input terminal of the single-mode optical fiber while light having the other binary phase pattern will be directed by the focusing optical unit to miss the input terminal of the single-mode optical fiber.

6. The device as in claim 1, wherein:

the phase mask device is configured to a fixed spatial binary phase pattern that causes a portion of the returned probe light from the epidermis part of the finger to miss the input terminal of the single-mode optical fiber and causes a portion of the returned probe light from the dermis part of the finger to enter the input terminal of the single-mode optical fiber.

7. The device as in claim 1, wherein:

the phase mask device is configured to produce an adjustable spatial binary phase pattern that can be changed in response to a control signal.

8. The device as in claim 7, wherein:

the phase mask device includes an electro-optic plate that produces the adjustable spatial binary phase pattern that can be changed in response to an electrical control signal.

9. The device as in claim 8, wherein:

the electro-optic plate of the phase mask device includes an electro-optic substrate having a first substrate surface and an second opposing substrate surface, one or more patterned transparent electrodes formed on the first substrate surface to divide the electro-optic substrate into different binary phase regions, and a common transparent electrode formed on the second substrate surface.

10. The device as in claim 7, wherein:

the phase mask device includes a magneto-optic plate that produces the adjustable spatial binary phase pattern that can be changed in response to a control signal.

11. The device as in claim 7, wherein:

the phase mask device includes a micro-electro-mechanical system (MEMS) that produces the adjustable spatial binary phase pattern that can be changed in response to a control signal.

12. The device as in claim 1, wherein:

the phase mask device is optically reflective to impose a spatial binary phase pattern onto reflected light.

13. The device as in claim 1, wherein:

the phase mask device is optically transmissive to impose a spatial binary phase pattern onto transmitted light that passes through the phase mask device.

14. The device as in claim 1, wherein:

the light source produces the probe light of different wavelengths to enable detect information of a [blood] glucose level at the different wavelengths.

15. The device as in claim 14, wherein:

the light source includes different light sources of different wavelengths.

16. The device as in claim 14, wherein:

the light source includes a single light source that emits light of different wavelengths.

17. The device as in claim 1, comprising:

a second single-mode optical fiber segment located inside the device housing between the light source and the beam splitter to guide the probe light from the light source towards the optical window by transmitting through the beam splitter; and

a large-core fiber segment located inside the device housing between the beam splitter and the phase mask device to deliver the returned probe light from the beam splitter over a distance to the phase mask device.

18. The device as in claim 1, comprising:

a beam scanner located inside the device housing between the optical window and the beam splitter to scan a direction of the probe light on the optical window to direct the probe light onto different locations of the finger.

19. The device as in claim 1, wherein:

the device housing includes a display unit that displays detected [blood] glucose information from the detector module.

20. The device as in claim 1, comprising:

an optical beam splitter located inside the device housing in an optical path of the returned probe light between the phase mask device and the optical window, the optical beam splitter located to transmit the probe light from the light source towards the optical window while reflecting the returned probe light into the phase mask device.

21. A non-invasive [blood] glucose testing device without using a blood sample, comprising:

a device housing that forms an enclosure;

a plate in the device housing that is structured to include an optical window that transmits light and provides a surface for a person to place a finger for performing a [blood] glucose test;

a light source located inside the device housing to produce probe light that transmits through the optical window to reach the finger for performing the [blood] glucose test;

a single-mode optical fiber segment located inside the device housing and configured to include a first terminal located to receive the probe light from the light source and a second terminal to output the received probe light from the light source towards the optical window and to collect light returned by the optical window;

a phase mask device located inside the device housing in an optical path between the optical window and the second terminal of the single-mode fiber segment and is optically transmissive to allow light to transmit therethrough, the phase mask device configured to exert one or more spatial binary phase patterns onto light that transmits therethrough;

a focusing optical unit located inside the device housing in an optical path between the phase mask device and the second terminal of the single-mode optical fiber to focus a portion of the returned probe light from the phase mask into an optical mode of the second terminal of the single-mode optical fiber while directing remainder of the returned probe light from the phase mask to miss the second terminal of the single-mode optical fiber, wherein the one or more spatial binary phase patterns are configured to cause the returned probe light at the input terminal to be in an optical mode different from the optical mode of the single-mode optical fiber; and

an optical detection module located inside the device housing and positioned to receive output light from the first terminal of the single-mode optical fiber segment to produce a detection output containing information of a [blood] glucose level.

22. The device as in claim 21, wherein:

the phase mask device is configured so that each spatial binary phase pattern includes two or more different binary phase regions of phase values of zero or π

.

23. The device as in claim 21, wherein:

the phase mask device is configured so that each spatial binary phase pattern includes two or more different binary phase regions that have different phase values between two adjacent binary phase regions.

24. The device as in claim 21, wherein:

the phase mask device is configured so that each spatial binary phase pattern includes two or more different binary phase regions that cause a portion of the returned probe light from the epidermis part of the finger to miss the input terminal of the single-mode optical fiber and cause a portion of the returned probe light from the dermis part of the finger to enter the input terminal of the single-mode optical fiber.

25. The device as in claim 21, wherein:

the phase mask device is configured to produce two or more different spatial binary phase patterns each having two or more different binary phase regions so that two different spatial binary phase patterns are mutually orthogonal in that light having one binary phase pattern can be directed by the focusing optical unit into the input terminal of the single-mode optical fiber while light having the other binary phase pattern will be directed by the focusing optical unit to miss the input terminal of the single-mode optical fiber.

26. The device as in claim 21, wherein:

the phase mask device is configured to a fixed spatial binary phase pattern that causes a portion of the returned probe light from the epidermis part of the finger to miss the input terminal of the single-mode optical fiber and causes a portion of the returned probe light from the dermis part of the finger to enter the input terminal of the single-mode optical fiber.

27. The device as in claim 21, wherein:

the phase mask device is configured to produce an adjustable spatial binary phase pattern that can be changed in response to a control signal.

28. The device as in claim 27, wherein:

the phase mask device includes an electro-optic plate that produces the adjustable spatial binary phase pattern that can be changed in response to an electrical control signal.

29. The device as in claim 28, wherein:

the electro-optic plate of the phase mask device includes an electro-optic substrate having a first substrate surface and an second opposing substrate surface, one or more patterned transparent electrodes formed on the first substrate surface to divide the electro-optic substrate into different binary phase regions, and a common transparent electrode formed on the second substrate surface.

30. The device as in claim 27, wherein:

the phase mask device includes a magneto-optic plate that produces the adjustable spatial binary phase pattern that can be changed in response to a control signal.

31. The device as in claim 27, wherein:

the phase mask device includes a micro-electro-mechanical system (MEMS) that produces the adjustable spatial binary phase pattern that can be changed in response to a control signal.

32. The device as in claim 21, wherein:

the light source produces the probe light of different wavelengths to enable detect information of a [blood] glucose level at the different wavelengths.

33. The device as in claim 32, wherein:

the light source includes different light sources of different wavelengths.

34. The device as in claim 32, wherein:

the light source includes a single light source that emits light of different wavelengths.

35. The device as in claim 21, comprising:

a second single-mode optical fiber segment located inside the device housing between the light source and the beam splitter to guide the probe light from the light source towards the optical window by transmitting through the beam splitter; and

a large-core fiber segment located inside the device housing between the beam splitter and the phase mask device to deliver the returned probe light from the beam splitter over a distance to the phase mask device.

36. The device as in claim 21, comprising:

a beam scanner located inside the device housing between the optical window and the beam splitter to scan a direction of the probe light on the optical window to direct the probe light onto different locations of the finger.

37. The device as in claim 21, wherein:

the device housing includes a display unit that displays detected [blood] glucose information from the detector module.